Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH, DARPA and FDA Collaborate to Develop Cutting-Edge Technologies to Predict Drug Safety

Published: Monday, September 19, 2011
Last Updated: Monday, September 19, 2011
Bookmark and Share
The collaboration will develop a chip to screen for safe and effective drugs far more swiftly and efficiently than current methods, and before they are tested in humans.

President Obama announces that the National Institutes of Health will collaborate with the Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug Administration to develop a chip loaded with specific cell types that reflect human biology. The chip will be designed to allow multiple different readouts that can indicate whether a particular compound is likely to be safe or toxic for humans. DARPA and NIH will run separate and independent programs, but they will work closely to ensure maximum benefit and efficiencies. For example, DARPA and NIH will facilitate collaborations between researchers and FDA to advance the goals of both programs. This fall, the two agencies, in coordination with FDA, will solicit proposals from industry, government labs, academic institutions, and other research organizations on how best to develop the chip, bringing together the latest advances in engineering, biology, and toxicology to bear on this complex problem.

"Drug toxicity is one of the most common reasons why promising compounds fail," Francis S. Collins, M.D., Ph.D., NIH director said. "We need to know which ones are safe and effective much earlier on in the process. This is an unprecedented opportunity to speed development of effective therapies, while saving time and money."

Over the next five years, the NIH plans to commit up to $70 million and DARPA will commit a comparable amount to this effort. This groundbreaking effort is an example of the types of innovative projects that would be led by the proposed National Center for Advancing Translational Sciences (NCATS). NCATS would help identify barriers to progress and provide science-based solutions to reduce costs and the time required to develop new drugs and diagnostics. FDA will help determine how this new technology can be utilized to assess drug safety, prior to approval for first-in-human studies.

"We know the development pipeline has bottlenecks in it, and everyone would benefit from fixing them,"Collins said. "What we need are entirely novel approaches to translational science, to take full advantage of the deluge of new biomedical discoveries that have been made in recent years."
As proposed, NCATS will study the steps in the process of diagnostics and therapeutics development, identify the bottlenecks, and experiment with innovative methods to streamline the process. By focusing on developing innovative new tools and methods for therapeutics development, as opposed to developing therapeutics themselves, NCATS will enable others to bring safer and more effective medical products to market in less time. In this way, NCATS will complement, and not compete with, the work of the private sector and other NIH translational science efforts.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Saturday, July 18, 2015
NIH Funds Nine Antimicrobial Resistance Diagnostics Projects
Investigators to develop tools to detect hospital-associated pathogens.
Friday, April 10, 2015
NIH Funds Next Phase of Tissue Chip for Drug Screening Program
Scientists will integrate chips mimicking human organ functions into full body system to evaluate drugs.
Thursday, September 25, 2014
NIH Awards $14.5M for DNA Sequencing Techniques
For the past several years, nanopore research has been an important focus of the program’s grants.
Tuesday, August 05, 2014
NIH Funds Development of Tissue Chips to Help Predict Drug Safety
DARPA and FDA to collaborate on therapeutic development initiative.
Wednesday, July 25, 2012
NIH Study Identifies Gene that Suppresses Cell's Immune Activation
FOXO3 gene suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
Wednesday, April 06, 2011
Scientific News
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Unravelling the Mysteries of Carbonic Acid
Researchers have shown how gaseous carbon dioxide molecules are solvated by water to initiate the proton transfer chemistry that produces carbonic acid and bicarbonate.
Injectable Device Delivers Nano-View of the Brain
A team of researchers has developed a method of fabricating nanoscale electronic scaffolds that can be injected via syringe.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!